Health Officials Raise Alarm on the Rising Threat of a Diarrhea-Causing Superbug
Prepare yourselves, folks: a superbug version of Shigella bacteria, a frequent source of diarrhea, is becoming a serious issue. This bacterial strain is showing an alarming resistance to all standard antibiotics.
Government health officials have recently released a comprehensive report that highlights this growing concern. Their study reveals an escalating number of Shigella cases nationwide since 2011, demonstrating resistance to conventional antibiotics. The health officials are urging for more extensive measures to be taken to prevent, monitor, and develop new treatments for this escalating public health risk.
The Emergence of Resilient Bacteria
“Shigella infection that is resistant to multiple drugs is a growing worry in the United States,” is the clear warning in the report, which was published recently.
Antibiotic resistance has evolved into a global public health menace. Bacteria that are resistant to antibiotics are estimated to cause over 1.2 million deaths around the globe each year. By 2050, this annual death toll could skyrocket to 10 million, matching the yearly death rate from cancer.
Among the various kinds of superbug bacteria, the extensively drug-resistant (XDR) Shigella strain might be one of the most alarming. This bacterium can withstand all categories of antibiotics typically used for treatment, such as azithromycin, ceftriaxone, and ciprofloxacin. Presently, no oral antibiotic is approved to treat these resilient infections.
Increasing Cases of Resistant Shigellosis
Shigella infection, also known as shigellosis, is a disease that doctors are required to report to their health departments. Since 2015, there has been a noticeable rise in cases of XDR shigellosis. The report's authors indicate that the patterns of this increase have not been thoroughly examined until now.
The investigators analyzed data gathered from a national laboratory network that identifies and tracks bacteria causing food- and waterborne outbreaks. They specifically looked at samples of Shigella bacteria sent to labs across the country between 2011 and 2023.
The study found no samples containing XDR Shigella between 2011 and 2015. However, by 2023, 8.5% of the samples tested that year showed extensive resistance. Two-thirds of these cases were from Shigella sonnei, the most common cause of shigellosis, while the remaining were from Shigella flexneri. Three-quarters of the cases reported no recent travel, indicating local transmission of the infection. In cases with available data, a third required hospitalization due to their infection, although no deaths were reported.
The Growing Threat of Shigellosis
Shigellosis is often an unpleasant experience, with symptoms including diarrhea, fever, and stomach pain. The infection typically resolves within a week without the need for antibiotics. However, these medications are crucial for treating severe cases and preventing life-threatening illness in high-risk groups like individuals with weakened immune systems.
It's estimated that Shigella bacteria infect 450,000 Americans each year. Shigella can spread through contaminated food and water and close sexual contact, particularly anal sex. This latter mode of transmission appears to be a primary reason why recent outbreaks of XDR Shigella have been concentrated among men who have sex with men.
The real concern isn't just the bacteria themselves, but the resistance genes they've developed. Some of these resistance genes can potentially transfer to other bacteria commonly found in the gut. This risk, along with the highly contagious nature of these bacteria, only intensifies their threat to public health.
Health experts recommend that doctors should depend on lab testing to guide their treatment of suspected Shigella infections whenever possible. They should also promptly report XDR cases to help prevent outbreaks. It will also be crucial to identify or develop antibiotics that can effectively treat these infections.
